The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health and social care, including kidney disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Funding opportunities are openly published on the NIHR website, which is available at the following link:

https://www.nihr.ac.uk/

One can propose research topics to the NIHR at the following link: https://www.nihr.ac.uk/get-involved/suggest-a-research-topic

In the last five financial years between 2020/21 and 2024/25, the NIHR has spent £37,529,199 in direct research on kidney disease. Between 2020/21 and 2024/25, approximately 10,871 people participated in NIHR-supported kidney disease studies. In the same time period, 152 studies relating to kidney disease were supported through the NIHR Research Delivery Network, with 34 of these studies having recruitment sites in Surrey. There were 65 NIHR-funded research and career development awards focusing on kidney disease research started between 2020/21 and 2024/25, with a combined funding of approximately £44 million.

One can find out more information about the work NIHR does to support and deliver research into kidney disease, including case studies, on the NIHR website at the following link:

https://www.nihr.ac.uk/support-and-services/support-for-delivering-research/specialties-and-settings/specialties

I refer the hon. Member to the answer I gave to the hon. Member for Stockton West on 26 November 2025 to Question 93528.

No discussions have taken place between the Department of Health and Social Care and Department for Culture, Media and Sport about young people with Down syndrome in Surrey and the role of sport in health outcomes.

The UK Chief Medical Officers’ physical activity guidelines for disabled young people sets out the benefits of movement and strength activities, which includes helping to support disabled young people’s well-being, mood, development of healthy muscles, balance, and motor skills.

Through our 10-Year Health Plan, Government departments are working together to break down the barriers people face and help get more people moving. This includes development of a national plan for physical activity and a new way to deliver physical education, sport, and physical activity in schools. This work provides us with opportunities to improve ways for disabled young people to enjoy and benefit from sport, play and physical activity, whether in school, through local sports clubs, or in leisure centres and play spaces, making use of parks and nature.

In April 2023, NHS England published a national framework and operational guidance for autism assessment services. This guidance intends to help the National Health Service improve autism assessment services and improve the experience for those referred to an autism assessment service. The guidance also set out what support should be available before an assessment and what support should follow a recent diagnosis of autism.

Since publication, NHS England has been supporting systems and services to identify where there are challenges for implementation and how they might overcome these.

NHS England established an attention deficit hyperactivity disorder (ADHD) taskforce which brought together those with lived experience with experts from the NHS, education, charity, and justice sectors to get a better understanding of the challenges affecting those with ADHD, including timely and equitable access to services and support. The final report was published on 6 November 2025, and we are carefully considering its recommendations.

Building on the work of the Independent ADHD Taskforce, my Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on the 4 December 2025 the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. The review will inform our approach so that people with ADHD and autistic people have the right support in place to enable them to live well in their communities.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, has regular discussions on a wide range of matters, including with trusts and integrated care boards (ICBs).

The Government has recognised that, nationally, demand for assessments for neurodevelopmental conditions such as autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support.

It is the responsibility of ICBs to make available appropriate provision to meet the health and care needs of their local population, including access to neurodevelopmental assessments.

Through the Medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.

It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population.

Children with developmental coordination disorder, commonly known as dyspraxia, access support through local National Health Service occupational therapy, paediatrics, physiotherapy, and educational services.

NHS guidance sets out a referral process which typically begins with a general practitioner, health visitor, or a Special Educational Needs Coordinator, who may refer the child to paediatric occupational therapy and physiotherapist for assessment and support. The NHS guidance is available at the following link:

https://www.nhs.uk/conditions/developmental-coordination-disorder-dyspraxia/

For the first time, we have set a target for systems to work to reduce long waits for community health services. By 2028/29 at least 80% of community health services activity should take place within 18 weeks, bringing community health services in line with targets for elective care.

Surrey Health provides occupational therapy support for children with dyspraxia of all ages. They provide speech and language therapy support for children under five years old who have verbal dyspraxia and a school aged speech and language therapy service for children over five years old.

Referrals for continence, occupational therapy, speech and language therapy and physiotherapy can be made directly by parents/carers as well as the child’s health visitor, general practitioner, therapist, early years’ service, hospital paediatricians, audiology service, Mindworks Surrey, and other agencies.

This is for speech and language therapy support for those under five years old, and therefore not in a school setting, and for occupational therapy of all ages. If a child is in school and requires speech and language therapy, the referral is through the school as the service is a school-based service.

The Medicines and Healthcare products Regulatory Agency (MHRA), acting on behalf of my Rt Hon. Friend, the Secretary of State for Health and Social Care, is responsible for the regulation of medicines intended for human use in the United Kingdom. This includes applying the legal controls on the retail sale, supply, and advertising of medicines, which are set out in the Human Medicines Regulations 2012.

Sourcing weight loss medicines from unregulated suppliers significantly increases the risk of receiving a product which is either falsified or not authorised for human use. Products purchased in this way will not meet the MHRA’s strict standards for quality, safety, and efficacy and can therefore expose patients to incorrect dosages or dangerous ingredients.

Public safety is the number one priority for the MHRA, and its Criminal Enforcement Unit works hard to prevent, detect, and investigate illegal activity involving medicines and medical devices and takes robust enforcement action where necessary. It works closely with other health regulators, customs authorities, law enforcement agencies, and private sector partners, including e-commerce and the internet industry to identify, remove and block online content promoting the illegal sale of medicines and medical devices.

The MHRA seeks to identify and, where appropriate, prosecute online sellers responsible for putting public health at risk. Between 1 April 2024 and 31 March 2025, the MHRA and its partners seized approximately 17 million doses of illegally traded medicines with a street value of more than £37 million.

During the same period, it disrupted approximately 190,000 website and social media links responsible for advertising medicinal products illegally. Additionally, collaboration with one well-known online marketplace led to the successful identification and blocking of more than 1.5 million unregulated prescription medicines, over-the-counter medicines, and medical devices before they could be offered for sale to the public.

The MHRA is continually developing new and innovative ways to combat the illegal trade in medicines and to raise public awareness. These measures include:

• publication of a #Fakemeds campaign which explains how to access medicines through safe and legitimate online sources, with further information available at the following link:
  https://fakemeds.campaign.gov.uk/;

• public guidance on how to safely access and use GLP-1 medications, available at the following link:
  https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know;

• development of an online service which allows the public to check if a website has been deemed ‘Not Recommended’ by the MHRA;

• development of a web-based reporting scheme allowing the public to report suspicious online sellers to the MHRA; and

• extensive work with media outlets to raise awareness of the dangers of illegal medicines.

The MHRA’s continued efforts have led to more medicines being seized than ever before, significant custodial sentences for offenders, the forfeiture of criminal profits and considerable success in disrupting the illegal supply of medicines.

The Medicines and Healthcare products Regulatory Agency (MHRA), acting on behalf of my Rt Hon. Friend, the Secretary of State for Health and Social Care, is responsible for the regulation of medicines intended for human use in the United Kingdom. This includes applying the legal controls on the retail sale, supply, and advertising of medicines, which are set out in the Human Medicines Regulations 2012.

Sourcing weight loss medicines from unregulated suppliers significantly increases the risk of receiving a product which is either falsified or not authorised for human use. Products purchased in this way will not meet the MHRA’s strict standards for quality, safety, and efficacy and can therefore expose patients to incorrect dosages or dangerous ingredients.

Public safety is the number one priority for the MHRA, and its Criminal Enforcement Unit works hard to prevent, detect, and investigate illegal activity involving medicines and medical devices and takes robust enforcement action where necessary. It works closely with other health regulators, customs authorities, law enforcement agencies, and private sector partners, including e-commerce and the internet industry to identify, remove and block online content promoting the illegal sale of medicines and medical devices.

The MHRA seeks to identify and, where appropriate, prosecute online sellers responsible for putting public health at risk. Between 1 April 2024 and 31 March 2025, the MHRA and its partners seized approximately 17 million doses of illegally traded medicines with a street value of more than £37 million.

During the same period, it disrupted approximately 190,000 website and social media links responsible for advertising medicinal products illegally. Additionally, collaboration with one well-known online marketplace led to the successful identification and blocking of more than 1.5 million unregulated prescription medicines, over-the-counter medicines, and medical devices before they could be offered for sale to the public.

The MHRA is continually developing new and innovative ways to combat the illegal trade in medicines and to raise public awareness. These measures include:

• publication of a #Fakemeds campaign which explains how to access medicines through safe and legitimate online sources, with further information available at the following link:
  https://fakemeds.campaign.gov.uk/;

• public guidance on how to safely access and use GLP-1 medications, available at the following link:
  https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know;

• development of an online service which allows the public to check if a website has been deemed ‘Not Recommended’ by the MHRA;

• development of a web-based reporting scheme allowing the public to report suspicious online sellers to the MHRA; and

• extensive work with media outlets to raise awareness of the dangers of illegal medicines.

The MHRA’s continued efforts have led to more medicines being seized than ever before, significant custodial sentences for offenders, the forfeiture of criminal profits and considerable success in disrupting the illegal supply of medicines.

The Urgent and Emergency Care plan for 2025/26 identifies reducing delays in hospital discharge as a key priority. Further information on the Urgent and Emergency Care plan for 2025/26 is available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/

Hospitals are expected to eliminate discharge delays of more than 48 hours caused by in-hospital issues, to work with local authorities to tackle the longest delays, starting with those over 21 days, and to profile discharges by pathway to support local planning. In addition to this, we published a new policy framework on 30 January 2025 for the £9 billion Better Care Fund policy framework 2025 to 2026, which requires the National Health Service and local authorities to jointly agree local goals for reducing discharge delays. Further information on the Better Care Fund policy framework 2025 to 2026 is available at the following link:

https://www.gov.uk/government/publications/better-care-fund-policy-framework-2025-to-2026

We are working with trusts, integrated care systems, and local authorities to share and embed best practice and to help them to use performance data more effectively to address their discharge delays. The Local Government Association has published a range of guidance documents and high impact change models to support improvements to hospital flow and discharge processes, which can be found at the following link:

https://www.local.gov.uk/our-support/partners-care-and-health/better-care-fund-support-programme-2025-26

Officials held a call on 18 July 2025 with the Epsom and St. Helier Trust regarding the trust’s discharge challenges and proposed actions to improve the situation.

The 10-Year Health Plan sets out ambitious plans to boost mental health support across the country, including in Surrey and the Surrey Heath constituency, for both men and women. This includes transforming mental health services into 24/7 neighbourhood mental health centres, improving assertive outreach, expanding talking therapies, and giving patients better access to 24/7 support directly through the NHS App.

The Suicide Prevention Strategy for England, published in 2023, identifies eight priority groups, including middle-aged men and pregnant women and new mothers, for targeted and tailored support at a national level. The strategy also identifies key risk factors for suicide, providing an opportunity for effective early intervention.

The purpose of the Suicide Prevention Strategy for England is to set out our aims to prevent suicide through action by working across the Government and other organisations. One of the key visions of the strategy is to reduce stigma surrounding suicide and mental health, so people feel able to seek help, including through the routes that work best for them. This includes raising awareness that no suicide is inevitable.

NHS England published Staying safe from suicide: Best practice guidance for safety assessment, formulation and management to support the Government’s work to reduce suicide and improve mental health services. The guidance requires all mental health practitioners to align their practice to the latest evidence in suicide prevention and is available at the following link:

https://www.england.nhs.uk/publication/staying-safe-from-suicide/

Through the Men’s Health Strategy, we are launching a groundbreaking partnership with the Premier League to tackle male suicide and improve mental health literacy, by embedding health messaging into the matchday experience.

We also announced the Suicide Prevention Support Pathfinders programme for middle-aged men. This program will invest up to £3.6 million over three years in areas of England where middle-aged men are at most risk taking their own lives and will tackle the barriers that they face in seeking support.

The 10-Year Health Plan sets out ambitious plans to boost mental health support across the country, including in Surrey and the Surrey Heath constituency, for both men and women. This includes transforming mental health services into 24/7 neighbourhood mental health centres, improving assertive outreach, expanding talking therapies, and giving patients better access to 24/7 support directly through the NHS App.

The Suicide Prevention Strategy for England, published in 2023, identifies eight priority groups, including middle-aged men and pregnant women and new mothers, for targeted and tailored support at a national level. The strategy also identifies key risk factors for suicide, providing an opportunity for effective early intervention.

The purpose of the Suicide Prevention Strategy for England is to set out our aims to prevent suicide through action by working across the Government and other organisations. One of the key visions of the strategy is to reduce stigma surrounding suicide and mental health, so people feel able to seek help, including through the routes that work best for them. This includes raising awareness that no suicide is inevitable.

NHS England published Staying safe from suicide: Best practice guidance for safety assessment, formulation and management to support the Government’s work to reduce suicide and improve mental health services. The guidance requires all mental health practitioners to align their practice to the latest evidence in suicide prevention and is available at the following link:

https://www.england.nhs.uk/publication/staying-safe-from-suicide/

Through the Men’s Health Strategy, we are launching a groundbreaking partnership with the Premier League to tackle male suicide and improve mental health literacy, by embedding health messaging into the matchday experience.

We also announced the Suicide Prevention Support Pathfinders programme for middle-aged men. This program will invest up to £3.6 million over three years in areas of England where middle-aged men are at most risk taking their own lives and will tackle the barriers that they face in seeking support.

The Government has recognised that, nationally, demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support. It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including provision of autism and ADHD services, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines.

The NICE guidance for the diagnosis of autism recommends that the length between referral and first appointment should be no more than 13 weeks. We know that this is not happening routinely across the country. In respect of ADHD, the NICE guideline does not recommend a maximum waiting time for people to receive an assessment for ADHD or a diagnosis, however it sets out best practice on providing a diagnosis.

Through the NHS Medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.

The Government has recognised that, nationally, demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support. It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including provision of autism and ADHD services, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines.

The NICE guidance for the diagnosis of autism recommends that the length between referral and first appointment should be no more than 13 weeks. We know that this is not happening routinely across the country. In respect of ADHD, the NICE guideline does not recommend a maximum waiting time for people to receive an assessment for ADHD or a diagnosis, however it sets out best practice on providing a diagnosis.

Through the NHS Medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.

The Government has recognised that, nationally, demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support. It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including provision of autism and ADHD services, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines.

The NICE guidance for the diagnosis of autism recommends that the length between referral and first appointment should be no more than 13 weeks. We know that this is not happening routinely across the country. In respect of ADHD, the NICE guideline does not recommend a maximum waiting time for people to receive an assessment for ADHD or a diagnosis, however it sets out best practice on providing a diagnosis.

Through the NHS Medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.

The Government is committed to tackling delayed discharges to ensure that people do not spend longer than necessary in hospital and to free up hospital beds. This year approximately £9 billion has been committed to the Better Care Fund (BCF) which requires integrated care boards and local authorities to make joint plans and pool budgets to deliver better joined-up care. This funding can be used flexibly to expand social care capacity, including home care and short-term reablement services.

From 2026/27, we will reform the BCF to ensure consistent joint funding for services essential to integrated health and social care such as hospital discharge, intermediate care, rehabilitation, and reablement.

The Government has recognised that, nationally, the demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support.

It is the responsibility of integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including providing access to autism and ADHD assessments, in line with relevant National Institute for Health and Care Excellence guidelines.

The Medium-Term Planning Framework, published 24 October, was explicit that ICBs and providers are expected to optimise existing resources to reduce long waits for autism and ADHD assessments and improve the quality of assessments by implementing existing and new guidance, as published.

In April 2023, NHS England published a national framework and operational guidance to help ICBs and the NHS to deliver improved outcomes for people referred to an autism assessment service. NHS England has continued to support services to identify challenges and how they might overcome these.  NHS England also established an ADHD taskforce to better understand the challenges affecting those with ADHD, including in accessing timely and equitable access to services and support. We are pleased that the final report was published on 6 November, and we are carefully considering its recommendations.

The Government has recognised that, nationally, the demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support.

It is the responsibility of integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including providing access to autism and ADHD assessments, in line with relevant National Institute for Health and Care Excellence guidelines.

The Medium-Term Planning Framework, published 24 October, was explicit that ICBs and providers are expected to optimise existing resources to reduce long waits for autism and ADHD assessments and improve the quality of assessments by implementing existing and new guidance, as published.

In April 2023, NHS England published a national framework and operational guidance to help ICBs and the NHS to deliver improved outcomes for people referred to an autism assessment service. NHS England has continued to support services to identify challenges and how they might overcome these.  NHS England also established an ADHD taskforce to better understand the challenges affecting those with ADHD, including in accessing timely and equitable access to services and support. We are pleased that the final report was published on 6 November, and we are carefully considering its recommendations.

My Rt Hon. Friend, the Secretary of State for Health and Social Care has had no such discussion with the Surrey Heartlands Integrated Care Board (ICB).

The National Institute for Health and Care Excellence’s (NICE) guidelines are developed by experts based on a thorough assessment of the available evidence and through extensive engagement with stakeholders. They are not mandatory, but National Health Service commissioners are expected to take them fully into account in designing services to meet the needs of their local populations.

The NHS Surrey Heartlands ICB advises that additional investment has been secured by the local system to increase capacity within the assessment pathway, and it is working to increase the earlier support available. The ICB is also continuing delivery of the Partnerships for the Inclusion of Neurodiversity in Schools programme, which brings together ICBs, local authorities, and schools, working in partnership with parents and carers to support schools to better meet the needs of neurodivergent children and their families.

The Department recognises that, for children and young people in distress or struggling with their mental health, fast access to early, high-quality support is critical. By intervening earlier, common mental health conditions can be prevented from developing into more serious conditions in later life and which require more costly interventions.

That is why the 10-Year Health Plan sets out how we will work with schools and colleges to better identify and meet children's mental health needs by continuing to fund the roll out of mental health support teams in schools and colleges to reach full national coverage by 2030 and embedding support for young people’s mental health in the new Young Futures Hubs, to ensure there is no 'wrong front door' for people seeking help. At the end of March 2025, 44% of pupils and learners in the hon. Member’s constituency and 27% across the whole of Surrey were covered by a mental health support team.

Additionally, we are continuing to provide top-up funding of £7 million to 24 existing early support hubs in 2025-26 to expand their services and take part in an ongoing evaluation of these services. This funding will enable the supported hubs to deliver at least 10,000 additional mental health and wellbeing interventions, so that more children and young people are supported.